These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21419755)
1. Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study. Leiviskä J; Sundvall J; Alfthan G; Jauhiainen M; Salomaa V Clin Chim Acta; 2011 May; 412(11-12):1146-50. PubMed ID: 21419755 [TBL] [Abstract][Full Text] [Related]
2. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease. Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851 [TBL] [Abstract][Full Text] [Related]
3. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609 [TBL] [Abstract][Full Text] [Related]
4. [Decrease ApoB/ApoA-1 ratio and cardiovascular risk improvement: a tadalafil pleiotropic effect? Preliminary study on healthy volunteers]. Roumeguère T; Zouaoui Boudjeltia K; Hauzeur C; Ramal A; Schulman C; Vanhaeverbeek M; Ducobu J; Wespes E Prog Urol; 2008 Dec; 18(13):1087-91. PubMed ID: 19041816 [TBL] [Abstract][Full Text] [Related]
5. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease. Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315 [TBL] [Abstract][Full Text] [Related]
6. Apolipoproteins A-I and B-markers in coronary risk evaluation. Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357 [TBL] [Abstract][Full Text] [Related]
7. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. Walldius G; Aastveit AH; Jungner I J Intern Med; 2006 Mar; 259(3):259-66. PubMed ID: 16476103 [TBL] [Abstract][Full Text] [Related]
8. apoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men. Schmidt C; Fagerberg B; Wikstrand J; Hulthe J Atherosclerosis; 2006 Nov; 189(1):178-85. PubMed ID: 16384562 [TBL] [Abstract][Full Text] [Related]
9. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy. Lundberg S; Gunnarsson I; Jacobson SH Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235 [TBL] [Abstract][Full Text] [Related]
10. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction. Dirisamer A; Stadler A; Bucek RA; Widhalm K Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176 [TBL] [Abstract][Full Text] [Related]
11. The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population. Belfki H; Ben Ali S; Bougatef S; Ben Ahmed D; Haddad N; Jmal A; Abdennebi M; Ben Romdhane H Exp Mol Pathol; 2011 Oct; 91(2):622-5. PubMed ID: 21801720 [TBL] [Abstract][Full Text] [Related]
12. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group. Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250 [TBL] [Abstract][Full Text] [Related]
13. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults. Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Meisinger C; Loewel H; Mraz W; Koenig W Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061 [TBL] [Abstract][Full Text] [Related]
15. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity. Kaneva AM; Potolitsyna NN; Bojko ER; Odland JØ Dis Markers; 2015; 2015():591454. PubMed ID: 25852220 [TBL] [Abstract][Full Text] [Related]
16. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. Walldius G; Jungner I J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855 [TBL] [Abstract][Full Text] [Related]
17. Moderate physical activity is associated with lower ApoB/ApoA-I ratios independently of other risk factors in healthy, middle-aged men. Behre C; Bergström G; Schmidt C Angiology; 2010 Nov; 61(8):775-9. PubMed ID: 20566576 [TBL] [Abstract][Full Text] [Related]
19. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. Holme I; Høstmark AT; Anderssen SA J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591 [TBL] [Abstract][Full Text] [Related]
20. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]